Grupo Argentino de Tratamiento de la Leucemia Aguda

8 clinical trials · Sponsor

Record	Firm	Date
Ibrutinib Adapted to Response in Patients With CLL (NCT05360758)	Grupo Argentino de Tratamiento de la Leucemia Aguda	2023-06-01
RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT (NCT04776265)	Grupo Argentino de Tratamiento de la Leucemia Aguda	2021-06-01
PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors (NCT05078840)	Grupo Argentino de Tratamiento de la Leucemia Aguda	2021-06-01
RWE of 1st Line Treatment With ATO/ATRA for Adult APL (NCT04897490)	Grupo Argentino de Tratamiento de la Leucemia Aguda	2021-03-01
RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old. (NCT05127798)	Grupo Argentino de Tratamiento de la Leucemia Aguda	2021-03-01
RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL (NCT05127148)	Grupo Argentino de Tratamiento de la Leucemia Aguda	2021-03-01
Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia (NCT06211452)	Grupo Argentino de Tratamiento de la Leucemia Aguda	2007-08-01
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia (NCT00002499)	Grupo Argentino de Tratamiento de la Leucemia Aguda	1990-01-01

Every clearance here is in the API, with alerts when new ones post.